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Abstract
Introduction: Minimally-invasive options for the management of choledocholithiasis in patients under-
going laparoscopic cholecystectomy include laparoscopic and endoscopic approaches. This study
reviews the effectiveness of both approaches in an emergency setting.
Methods: A retrospective chart review was performed for a cohort of patients who underwent
laparoscopic cholecystectomy. Outcomes assessed were duct clearance, the number of procedures
performed (NPP), length of stay (LOS) and complication rate.
Results: A total of 182 patients who underwent emergency laparoscopic cholecystectomies received
intervention for choledocholithiasis. The duct clearance rate was lower in the laparoscopic group, 63%
versus 86% (P = 0.001). However, the median NPP was also lesser in the laparoscopic group, 1
(interquartile range (IQR) 1–2) versus 2 (IQR 2–2) (P < 0.001), as was the median LOS, 5 days (IQR 3–8)
versus 7 days (IQR 6–10) (P = 0.009). Forty-eight laparoscopic endobiliary stents were attempted; stent
deployment was successful in 37 patients. A larger proportion of patients with laparoscopic endobiliary
stents had duct clearance by endoscopic retrograde cholangiopancreatography (ERCP) compared with
those without, although this was not statistically significant (P = 0.208).
Conclusion: Laparoscopic clearance is not as effective as post-operative ERCP in an emergency
cohort, but is associated with fewer procedures required and a shorter inpatient stay. Thus, laparoscopic
clearance may still be an attractive option for surgeons especially where conditions are favourable during
an emergency laparoscopic cholecystectomy.
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Introduction
Common bile duct stones, or choledocholithiasis, are common,
and may be primary i.e. stones that form de novo in the common
bile duct (CBD), or secondary, occurring in up to 10–20% of
patients with gallstones.1–3 In the era of minimally invasive
surgery, various endoscopic and laparoscopic approaches exist for
the management of choledocholithiasis in patients with an intact
gallbladder. These include a pre-, post- or intra-operative endo-
scopic retrograde cholangiopancreatography (ERCP), with or
without endoscopic sphincterotomy (ES), and laparoscopic
common bile duct exploration (LCBDE), either by transcystic
exploration (TCE) or via laparoscopic choledochotomy.4
The current literature surrounding the management of
choledocholithiasis in patients undergoing a laparoscopic chol-
ecystectomy suggests that ERCP and LCBDE have comparable
rates of duct clearance.5–10 Emergent intervention, including
laparoscopic cholecystectomy, in patients presenting acutely with
choledocholithiasis has been proven to be safe and efficacious.4,11–13
Previous studies have not considered the outcomes of endoscopic
versus laparoscopic approaches to choledocholithiasis in an emer-
gency cohort undergoing a laparoscopic cholecystectomy.
Monash Medical Centre is a tertiary referral hospital in metro-
politanVictoria,Australia.The unit is composed of a mix of general
surgeons with sub-specialty interests in upper gastrointestinal
and hepatopancreaticobiliary surgery. Patients with acute biliary
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symptoms tend to receive intervention on the emergency list,
rather than scheduled elective re-admission. Patients generally
have liver function tests and ultrasound (US) or computed tomog-
raphy (CT) of the abdomen/pelvis as part of their pre-operative
work-up. A minority have CT cholangiography or magnetic reso-
nance cholangiopancreatography (MRCP) pre-operatively as the
unit does not favour the use of pre-operative ERCP. However,
patients who are clinically unwell on admission, e.g. severe acute
cholangitis, may have pre-operative ERCP. In the absence of
contraindications, an intra-operative cholangiogram (IOC) is rou-
tinely performed at the time of a laparoscopic cholecystectomy and
a ‘laparoscopy-first’ approach to choledocholithiasis is advocated
i.e. where practicable, LCBDE is undertaken if stones are found on
IOC or if CBD stones are suspected or known to be present
pre-operatively, with post-operative ERCP reserved for those in
whom LCBDE is unsuccessful. However, a proportion of patients
receive post-operative ERCP without LCBDE in spite of CBD
stones being demonstrated on IOC for a number of reasons, e.g.
surgeon preference, operating time constraints.
The findings of a descriptive and comparative study based on a
retrospective series of patients with gallbladders in situ who
received emergency intervention for choledocholithiasis are pre-
sented below.
Methods
A retrospective chart review was performed for a cohort of
patients who underwent laparoscopic cholecystectomies over a
30-month period (July 2010 to December 2012). Both private and
public patients were included in the study.
Shortlisted records were reviewed and patients with evidence of
choledocholithiasis were noted. The presence of choledocho-
lithiasis was defined as stone(s) visualised by IOC, ERCP, choledo-
choscopy, CT cholangiography and/or MRCP.
Primary outcomes assessed were rates of duct clearance and
retained stones. Duct clearance was defined as a clear completion
IOC, occlusion cholangiogram, cholangioscopy, CT cholangio-
graphy, MRCP or clinical improvement where the former were
not practicable. Retained stones were determined based on further
procedure(s) being performed for duct clearance (within 2 years
of the previous procedure), and included expected and unexpec-
ted retained stones. A period of 2 years was arbitrarily assigned as
a time frame to distinguish between retained stones and de novo
(primary) CBD stones. Other outcomes assessed were the number
of procedures performed, length of stay (LOS) and the complica-
tion rate.
Patients were analysed in three groups on an intention-to-treat
basis: patients who received pre-operative ERCP (‘PRE’ group),
patients who had LCBDE (‘LCBDE’ group) without pre-operative
ERCP and the remaining patients i.e. those who had only post-
operative ERCP (‘POST’ group). Patients who ‘failed’ a particular
treatment i.e. had retained stones, may have had treatment crosso-
vers but were nonetheless analysed in their respective groups.
Data were analysed using GraphPad Prism 6.0 (GraphPad Soft-
ware, Inc., La Jolla, CA, USA). Categorical variables were evaluated
using Pearson’s χ2 test. Continuous variables were compared
using the Mann–Whitney U-test for non-parametric data.
ERCP
ERCP were performed using standard techniques with a side-
viewing duodenoscope. ES were performed using a bow-string
sphincterotome or needle knife. Balloon sphincteroplasties were
performed in a minority of patients. Stone clearance was achieved
using balloon extraction catheters or baskets under fluoroscopic
guidance. Endoscopic cholangioscopy and mechanical lithotripsy
were reserved for patients with recalcitrant stone disease. Biliary
or pancreatic drainage stents were deployed if indicated.
Laparoscopic CBD exploration (transcystic
exploration or via choledochotomy)
A trial of intravenous glucagon/butylscopolamine coupled with a
saline flush through the cystic duct was usually but not always
undertaken if stones were felt to be small enough to flush. TCE
were generally performed under fluoroscopic guidance. A 5-mm
flexible choledochoscope was used in a minority of patients in
place of fluoroscopy. Stone extraction was usually performed with
a Dormia-type basket, but Fogarty catheters were occasionally
used. A longitudinal, rather than transverse, choledochotomy was
favoured when performed. Stone extraction by laparoscopic
choledochotomy was performed under direct vision using a
5-mm flexible choledochoscope. Laparoscopic endobiliary stents
were deployed for biliary drainage when deemed necessary by the
operating surgeon.
Results
In total, 1119 laparoscopic cholecystectomies were performed at
our institution over the 30-month period. Of these, 744 (66%)
were emergency procedures and 375 (34%) were elective pro-
cedures. The overall laparoscopic-to-open conversion rate was
36/1119 (3%).
Two hundred and six patients (18%) with choledocholithiasis
were found amongst the cohort of laparoscopic cholecystectomy
patients: 24 patients (6%) from the elective cohort and 182 (24%)
from the emergency cohort had choledocholithiasis. The latter
182 patients constitute the study population. The median
follow-up duration was 17 months. There were five deaths during
the study period, four from unrelated causes and one peri-
procedural mortality.
Figure 1 shows the patient distribution according to the groups
they were analysed in and reflects our management approach to
choledocholithiasis. Table 1 shows the patient demographics for
the study population. Table 2 summarises the main study find-
ings. Table 3 shows the morbidity associated with each treatment
group.
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Thirty-three patients in the series received pre-operative ERCP.
The reasons for which this group received pre-operative ERCP are
outlined in Table 4. In the PRE group, seven patients were
excluded for the determination of the duct clearance rate as they
were clinically unsuitable for ES. All seven patients had endo-
scopic placement of biliary drainage stents. In two patients, failure
to clear the duct was as a result of an inability to cannulate the bile
duct.
Two patients subsequently had a laparoscopic cholecystectomy,
which were then converted to open surgery; neither required
further procedures for duct clearance. (One was converted for
open exploration and clearance of the CBD, the other because of
iatrogenic common hepatic duct injury.) The median time to a
laparoscopic cholecystectomy after pre-operative ERCP was 4 days
[interquartile range (IQR) 2–8].
Eighty-three patients had LCBDE attempted. Of these, 80 were
performed transcystically and 3 via a laparoscopic choledo-
chotomy. Sixty-six patients did not have attempted LCBDE and
proceeded directly to receive ERCP after a laparoscopic cholecys-
tectomy. The reasons for which LCBDE were not attempted in
these patients were examined and are outlined in Table 5.
The duct clearance rate by TCE included four patients whose
ducts were cleared by flushing with saline and two ducts which
were cleared serendipitously during stent deployment. (In the
latter two patients, stent deployment was only attempted after
failed TCE and stent retrieval was possible intra-operatively i.e. no
further procedures were required.) There was only one post-
procedural mortality in this group. After an unsuccessful TCE, the
patient underwent post-operative ERCP complicated by a duode-
nal perforation. The patient had sequential laparotomies but ulti-
mately deteriorated and passed away.
Two of the three patients who had laparoscopic choledo-
chotomies later required post-operative ERCP for removal of
laparoscopically-placed endobiliary stents and not for duct clear-
ance per se.
Forty-eight patients in the study had attempted placement of
laparoscopic endobiliary stents. Stent deployment was successful
in 37 patients. Eighteen stents were attempted only after failed
TCE, 26 stents were attempted without TCE and 4 stents were
placed after a laparoscopic choledochotomy. Stent placement was
associated with morbidity in two patients. The first patient pre-
sented acutely with pancreatitis secondary to a blocked stent
whereas the second patient presented with non-specific abdomi-
nal pain which was attributed to stent migration.
Sixty-six patients had ERCP without prior LCBDE. (In one
patient, ERCP was performed intra-operatively using regular
ERCP techniques and not lapendoscopic rendezvous.) Two
patients had prior a laparoscopic-to-open cholecystectomy; in
both patients, the surgeon’s preference was for post-operative
ERCP rather than open exploration for duct clearance. (One was
converted as a result of dense adhesions, the other for iatrogenic
common bile duct injury.) The median time to planned ERCP
after a laparoscopic cholecystectomy in patients without biliary
drainage stents in situ was 2 days (IQR 1–4).
Table 2 demonstrates the rates of duct clearance and retained
stones after one post-operative ERCP attempt. Failure to clear the
duct in the first post-operative ERCP attempt was related to an
inability to cannulate the bile duct in one patient. Patients who
had retained stones after post-operative ERCP received sequential
ERCP until duct clearance was achieved. All patients in the series
eventually had their ducts cleared by post-operative ERCP (max =
4). No patient in the study necessitated exploration of the
common bile duct (open or laparoscopic) as salvage for failed
post-operative ERCP.
Sub-group analysis for patients in the POST group for those
with and without laparoscopic endobiliary stents revealed that
those with stents in situ had a higher duct clearance rate (18 out of
19 patients) compared with those without (39 out of 47 patients),
although this failed to achieve statistical significance (P = 0.208).
Discussion
The majority of laparoscopic cholecystectomies in the study were
performed as emergency procedures. The number of patients with
concomitant choledocholithiasis was surprisingly high amongst
the emergency cohort (24%). This is partly accounted for by
the fact that the unit receives a large number of referrals from
peripheral hospitals for patients with confirmed or suspected
choledocholithiasis.
Table 1 reflects significant heterogeneity between treatment
groups. There is an elevated proportion of patients with ascending
cholangitis and raised total bilirubin in the PRE group. This prob-
ably reflects a selection bias for patients in the study who were
significantly more unwell compared with the other groups (see
Table 4).
The duct clearance rate by pre-operative ERCP in our series is
low compared with that of previous studies,7,8,10 with a corre-
spondingly high rate of retained stones (see Table 2). This could
Study population 182
Pre-op ERCP 33
Lap. cholecystectomy 149
LCBDE 83 Post-op ERCP 66
Choledochotomy 3 TCE 80
Figure 1 Patient distribution
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be a manifestation of the selection bias inherent in this group for
significantly unwell patients and large stones thought to be tech-
nically challenging for laparoscopic extraction. Endoscopists
would also have been unwilling to undertake large sphinctero-
tomies or sphincteroplasties in such an unwell population. The
raised percentage of patients with general complications in this
group is probably as a result of the fact that this group was com-
prised of older, sicker patients (see Tables 1 and 3).
This difference of 24% in the clearance rate between post-
operative ERCP and LCBDE was statistically significant (P =
0.001). The vast majority of patients in the group had their ducts
cleared within the first post-operative ERCP attempt (see Table 2).
Nonetheless, in terms of the median number of procedures
required for duct clearance, the LCBDE group achieved duct clear-
ance with fewer procedures compared with the POST group (P <
0.001). The LCBDE group also had a statistically significant
shorter median length of stay compared with the POST group
(P = 0.009).
The overall clearance rate by LCBDE in our study is lower than
recently reported rates.6–11 This might represent the fact that pre-
viously published studies have mostly been from highly special-
ised centres,10 but could also be the result of our low utilisation of
a laparoscopic choledochotomy. Achieving high clearance rates
with LCBDE requires a commitment to a laparoscopic choledo-
chotomy in situations where TCE may not be suitable, e.g. large
stones or unfavourable cystic ducts. Performance of a laparoscopic
choledochotomy is a technically challenging and time-consuming
procedure with a steep learning curve, which especially in an
emergency setting, could be difficult to undertake. The low rates
of laparoscopic choledochotomy in this series reflects the real-
world conditions of a busy tertiary referral surgical unit where
time pressure becomes an important factor in decision making.
The lack of access to a 3-mm flexible choledochoscope for TCE
might also have contributed to the lowered clearance rate as stone
extraction under direct vision could not be undertaken. The easy
accessibility of post-operative ERCP may have further discour-
aged the practice of LCBDE in perceived ‘difficult’ situations.
Unfortunately, the majority of patients who did not have
attempted LCBDE did not have the reasons for such clearly com-
municated in the operation report or findings (see Table 5).
Table 1 Patient demographics
PRE LCBDE POST Total
(n = 33) (n = 83) (n = 66) (n = 182)
Mean age, years 65.4 52.6 57.6 56.7
(range: 38–89) (range: 16–93) (range: 21–91) (range: 16–93)
Female, n 11 56 (67%) 35 (64%) 102 (56%)
Ascending cholangitis (ASC), n 18 10 (12%) 9 (14%) 37 (20%)
Gallstone pancreatitis (GSP), n 5 11 (13%) 10 (15%) 26 (14%)
ASC + GSP, n 4 2 (2%) 1 (2%) 7 (4%)
TBil > 50 μmol/l, n 22 33 (40%) 19 (29%) 74 (41%)
Pre-operative MRCP, n 4 5 (6%) 6 (9%) 15 (8%)
Pre-operative CT cholangiogram, n 2 2 (2%) 2 (3%) 6 (3%)
LCBDE, laparoscopic common bile duct exploration.
Table 2 Main study findings
PRE
(n = 33)
LCBDE POST
(n = 66)
P valuea
TCE
(n = 80)
Choledochotomy
(n = 3)
Combined
(n = 83)
Duct clearance, n 15b 49 3 52 57 0.001
(61%) (63%) (86%)
Retained stones, n 15 36 0 36 10 <0.001
(45%) (43%) (15%)
No. of procedures median: 2 median: 1 median: 2 median: 1 median: 2 <0.001
(IQR 2–3) (IQR 1–2) (IQR 1–2) (IQR 1–2) (IQR 2-2)
Length of stay, days median: 13 median: 5 median: 7 median: 5 median: 7 0.009
(IQR 8–18) (IQR 3–9) (IQR 5–7) (IQR 3–8) (IQR 6–10)
LCBDE, laparoscopic common bile duct exploration, TCE, transcystic exploration; IQR, interquartile range.
aComparison between the last two columns.
bSeven patients were excluded as they were clinically unsuitable for an endoscopic sphincterotomy (see text).
632 HPB
HPB 2014, 16, 629–634 © 2013 International Hepato-Pancreato-Biliary Association
Laparoscopic endobiliary stents are a useful adjunct in terms of
achieving a reliable means of biliary drainage when duct clearance
is not possible or not practicable, e.g. owing to operating time
constraints. Stent placement was associated with morbidity in
only two patients in the series. The placement of laparoscopic
endobiliary stents may improve duct clearance rates although this
was not statistically significant, probably because of the small
sample size.
Much of the existing literature have addressed the issue of
endoscopic versus laparoscopic approaches to choledocholithia-
sis, however, none have specifically looked at both approaches in
an emergency laparoscopic cholecystectomy cohort. Issues such as
time constraints and operating speed need to be factored into the
decision-making process when handling emergency patients.
These pose further challenges to the surgeon in terms of deter-
mining the best approach to undertake in the face of a technically-
complex bile duct stone(s) during an emergency laparoscopic
cholecystectomy.
This study is limited by its retrospective nature and the inherent
bias present amongst the groups. Intra-operative ERCP permits
duct clearance in a single sitting and may thus provide the benefits
associated with LCBDE. We have designed a randomised, open-
label trial comparing LCBDE against intra-operative ERCP in
a prospective cohort of patients scheduled for an emergency
laparoscopic cholecystectomy. The trial has received ethics
approval and is currently underway.
Conclusions
The findings of this study suggest that duct clearance rates by
LCBDE may not be as high as post-operative ERCP in an emer-
gency cohort. However, the former was able to achieve duct clear-
ance in a single session in the majority, with attendant benefits of
fewer procedures required and a reduced inpatient LOS. Hence,
LCBDE, or at least TCE, may still be an attractive option for
surgeons when faced with choledocholithiasis in patients under-
going an emergency laparoscopic cholecystectomy especially
where the stone(s) and patient anatomy are favourable and oper-
ating schedules permit. Laparoscopic endobiliary stents are a safe
alternative and may be useful in an acute setting especially when
faced with operating time constraints, regardless whether or not
LCBDE is undertaken, and may improve duct clearance rates by
post-operative ERCP. Where feasible, intra-operative ERCP may
be the best option for patients undergoing an emergency
laparoscopic cholecystectomy, although this merits further study.
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